S100A9 and myelodysplastic syndrome: Indeed, S100A9 could mediate the activation of NOX that generates ROS, contributing to inflammasome assembly and inflammatory cytokine production, β-catenin activation, and thereby trigger pyroptosis in MDS bone marrow mononuclear cells (BM-MNCs) [48].